MUMSS
IDXX icon

Mitsubishi UFJ Morgan Stanley Securities’s Idexx Laboratories IDXX Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed -$3K – 202
2022
Q3 		$3K Hold
10
– – 0.04% 158
2022
Q2 		$4K Hold
10
– – 0.01% 154
2022
Q1 		$5K Sell
10
-30
-75% -$15.8K ﹤0.01% 149
2021
Q4 		$26K Sell
40
-50
-56% -$31.4K 0.01% 118
2021
Q3 		$56K Sell
90
-40
-31% -$26.9K 0.05% 64
2021
Q2 		$82K Buy
+130
New +$71.8K 0.61% 32

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mitsubishi UFJ Morgan Stanley Securities's IDXX Position: Q4 2022 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 10 shares — an estimated $3K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in IDXX in Q2 2021 and held it in 6 quarters. The position peaked at $82K in Q2 2021. 1,000 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 10 Idexx Laboratories shares in Q4 2022, an estimated $3K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Idexx Laboratories in Q2 2021 and held it in 6 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Idexx Laboratories position peaked at $82K in Q2 2021.
  • 1,000 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q4 2022, filed 24 Jan 2023.